ZFIN ID: ZDB-FISH-180906-2
Fish name: lft1a145/a145 ; lft2a146/a146
Genotype: lft1a145/a145 ; lft2a146/a146
Targeting Reagent: none
HUMAN DISEASE MODELED by lft1a145/a145 ; lft2a146/a146
No data available
GENE EXPRESSION
Gene expression in lft1a145/a145 ; lft2a146/a146
Reporter gene expression No data available
PHENOTYPE
Phenotype in lft1a145/a145 ; lft2a146/a146
Phenotype Conditions Figures
axis noto expression amount, ameliorated chemical treatment by environment: SB 505124 Fig. 6 with imageFig. 6-S3 with image from Rogers et al., 2017
axis bifurcated, abnormal standard conditions Fig. 1-S2 with image from Rogers et al., 2017
axis lft1 expression increased amount, abnormal standard conditions Fig. 3-S1 with image from Rogers et al., 2017
axis noto expression increased amount, abnormal standard conditions Fig. 4 with imageFig. 6 with imageFig. 6-S3 with image from Rogers et al., 2017
axis lft2 expression increased amount, abnormal standard conditions Fig. 3-S1 with image from Rogers et al., 2017
axis ndr2 expression increased amount, abnormal standard conditions Fig. 3-S1 with image from Rogers et al., 2017
axis noto expression increased distribution, abnormal standard conditions Fig. 4 with imageFig. 6 with imageFig. 6-S3 with image from Rogers et al., 2017
axis lft1 expression increased distribution, abnormal standard conditions Fig. 3-S1 with image from Rogers et al., 2017
axis ndr2 expression increased distribution, abnormal standard conditions Fig. 3-S1 with image from Rogers et al., 2017
axis lft2 expression increased distribution, abnormal standard conditions Fig. 3-S1 with image from Rogers et al., 2017
axis lft1 expression spatial pattern, abnormal standard conditions Fig. 3-S1 with image from Rogers et al., 2017
axis noto expression spatial pattern, abnormal standard conditions Fig. 4 with imageFig. 6 with imageFig. 6-S3 with image from Rogers et al., 2017
axis lft2 expression spatial pattern, abnormal standard conditions Fig. 3-S1 with image from Rogers et al., 2017
axis noto expression spatial pattern, ameliorated chemical treatment by environment: SB 505124 Fig. 6 with imageFig. 6-S3 with image from Rogers et al., 2017
blastodisc anatomical margin lft1 expression increased amount, abnormal standard conditions Fig. 3-S1 with image from Rogers et al., 2017
caudal fin aplastic, abnormal standard conditions Fig. 1 with image from Rogers et al., 2017
caudal fin curved dorsal, abnormal standard conditions Fig. 6-S1 with image from Rogers et al., 2017
caudal fin decreased length, abnormal standard conditions Fig. 1 with imageFig. 6 with imageFig. 6-S1 with image from Rogers et al., 2017
caudal fin length, ameliorated chemical treatment by environment: SB 505124 Fig. 6 with imageFig. 6-S1 with imageFig. 6-S2 with image from Rogers et al., 2017
caudal fin morphology, abnormal standard conditions Fig. 1 with imageFig. 6 with imageFig. 6-S1 with image from Rogers et al., 2017
caudal fin morphology, ameliorated chemical treatment by environment: SB 505124 Fig. 6 with imageFig. 6-S1 with imageFig. 6-S2 with image from Rogers et al., 2017
embryonic pattern specification decreased process quality, abnormal standard conditions Fig. 1 with image from Rogers et al., 2017
endoderm sox32 expression amount, ameliorated chemical treatment by environment: SB 505124 Fig. 6 with imageFig. 6-S3 with image from Rogers et al., 2017
endoderm sox32 expression increased amount, abnormal standard conditions Fig. 3 with imageFig. 4 with imageFig. 6 with imageFig. 6-S3 with image from Rogers et al., 2017
endoderm sox17 expression increased amount, abnormal standard conditions Fig. 3-S1 with image from Rogers et al., 2017
endoderm sox32 expression increased distribution, abnormal standard conditions Fig. 3 with imageFig. 4 with imageFig. 6 with imageFig. 6-S3 with image from Rogers et al., 2017
endoderm sox17 expression increased distribution, abnormal standard conditions Fig. 3-S1 with image from Rogers et al., 2017
endoderm sox17 expression spatial pattern, abnormal standard conditions Fig. 3-S1 with image from Rogers et al., 2017
endoderm sox32 expression spatial pattern, abnormal standard conditions Fig. 3 with imageFig. 4 with imageFig. 6 with imageFig. 6-S3 with image from Rogers et al., 2017
endoderm sox32 expression spatial pattern, ameliorated chemical treatment by environment: SB 505124 Fig. 6 with imageFig. 6-S3 with image from Rogers et al., 2017
eye aplastic, abnormal standard conditions Fig. 1 with imageFig. 6 with imageFig. 6-S1 with image from Rogers et al., 2017
eye morphology, abnormal standard conditions Fig. 6 with imageFig. 6-S1 with image from Rogers et al., 2017
eye morphology, ameliorated chemical treatment by environment: SB 505124 Fig. 6 with imageFig. 6-S1 with imageFig. 6-S2 with image from Rogers et al., 2017
gastrulation process quality, normal standard conditions Fig. 1-S2 with image from Rogers et al., 2017
heart aplastic, abnormal standard conditions Fig. 1 with image from Rogers et al., 2017
heart tube myl7 expression absent, abnormal standard conditions Fig. 1-S1 with image from Rogers et al., 2017
heart tube aplastic, abnormal standard conditions Fig. 1-S1 with image from Rogers et al., 2017
margin noto expression decreased amount, abnormal standard conditions Fig. 6-S3 with image from Rogers et al., 2017
margin sox32 expression decreased amount, abnormal chemical treatment by environment: SB 505124 Fig. 6-S3 with image from Rogers et al., 2017
margin lft2 expression increased amount, abnormal standard conditions Fig. 3-S1 with image from Rogers et al., 2017
margin sox32 expression increased amount, abnormal standard conditions Fig. 4 with image from Rogers et al., 2017
margin lft1 expression increased amount, abnormal standard conditions Fig. 3-S1 with image from Rogers et al., 2017
margin ndr1 expression increased amount, abnormal standard conditions Fig. 3-S1 with image from Rogers et al., 2017
margin lft1 expression increased distribution, abnormal standard conditions Fig. 3-S1 with image from Rogers et al., 2017
margin ndr1 expression increased distribution, abnormal standard conditions Fig. 3-S1 with image from Rogers et al., 2017
margin lft2 expression increased distribution, abnormal standard conditions Fig. 3-S1 with image from Rogers et al., 2017
margin sox32 expression increased distribution, abnormal standard conditions Fig. 4 with imageFig. 6-S3 with image from Rogers et al., 2017
margin sox32 expression spatial pattern, abnormal standard conditions Fig. 4 with imageFig. 6-S3 with image from Rogers et al., 2017
margin lft2 expression spatial pattern, abnormal standard conditions Fig. 3-S1 with image from Rogers et al., 2017
margin lft1 expression spatial pattern, abnormal standard conditions Fig. 3-S1 with image from Rogers et al., 2017
mesoderm noto expression increased amount, abnormal standard conditions Fig. 3 with image from Rogers et al., 2017
mesoderm noto expression increased distribution, abnormal standard conditions Fig. 3 with image from Rogers et al., 2017
mesoderm noto expression spatial pattern, abnormal standard conditions Fig. 3 with image from Rogers et al., 2017
presumptive endoderm sox32 expression increased amount, abnormal standard conditions Fig. 3 with image from Rogers et al., 2017
presumptive endoderm sox32 expression increased distribution, abnormal standard conditions Fig. 3 with image from Rogers et al., 2017
presumptive endoderm sox32 expression spatial pattern, abnormal standard conditions Fig. 3 with image from Rogers et al., 2017
presumptive mesoderm noto expression increased amount, abnormal standard conditions Fig. 3 with image from Rogers et al., 2017
presumptive mesoderm noto expression increased distribution, abnormal standard conditions Fig. 3 with image from Rogers et al., 2017
presumptive mesoderm noto expression spatial pattern, abnormal standard conditions Fig. 3 with image from Rogers et al., 2017
whole organism alive, normal standard conditions Fig. 1-S2 with image from Rogers et al., 2017
whole organism decreased length, abnormal standard conditions Fig. 6 with imageFig. 6-S1 with image from Rogers et al., 2017
whole organism fertile, normal chemical treatment by environment: SB 505124 Fig. 6-S2 with image from Rogers et al., 2017
whole organism Ab9-smad2 labeling increased amount, abnormal standard conditions Fig. 2 with imageFig. 2-S1 with image from Rogers et al., 2017
whole organism Ab9-smad2 labeling increased distribution, abnormal standard conditions Fig. 2 with image from Rogers et al., 2017
whole organism morphology, abnormal standard conditions Fig. 6 with imageFig. 6-S1 with image from Rogers et al., 2017
whole organism morphology, ameliorated chemical treatment by environment: SB 505124 Fig. 6 with imageFig. 6-S1 with image from Rogers et al., 2017
whole organism necrotic, abnormal standard conditions Fig. 6 with image from Rogers et al., 2017

CITATIONS  (1)